Semax 10mg

Semax – 10mg

ACTH(4‑10) Analog • Lyophilized Peptide • Research Use Only

Description: Semax is a synthetic peptide derivative of adrenocorticotropic hormone (ACTH 4‑10), extensively studied for its neuroprotective, nootropic, and neuromodulatory properties. Originally developed in Russia, Semax is of significant interest for its ability to influence brain‑derived neurotrophic factor (BDNF) expression and modulate key neurotransmitter systems, including dopaminergic, serotonergic, and glutamatergic pathways.

Research models highlight Semax’s potential in supporting cognitive performance, memory formation, stress resilience, and recovery from neurological injury, making it a central compound in neurobiology and cognitive‑enhancement studies.

Specifications

• Compound: Semax

• Purity: ≥99.8%

• Form: Lyophilized powder

• Quantity: 10mg per vial

• Storage:

  • Store lyophilized at –20°C (–4°F)

  • After reconstitution, refrigerate at 2–8°C (36–46°F); use within 30 days

• Grade: Research Use Only — Not for human consumption or therapeutic use

Research Focus Areas

• Neuroprotection and brain‑injury recovery models

• Cognitive enhancement and memory‑function studies

• BDNF modulation and neurotrophic‑factor research

• Stress resilience and mood‑regulation pathways

• Neurotransmitter activity and synaptic‑plasticity investigations

Mechanistic Interest

Semax is studied for its ability to:

• Upregulate BDNF and support neurotrophic signaling

• Enhance synaptic plasticity, learning, and memory

• Modulate dopamine, serotonin, and glutamate pathways

• Provide neuroprotection against ischemic and oxidative stress

• Influence stress‑response systems and behavioral regulation

Its broad neuroactive profile makes Semax a key peptide in nootropic, neuroprotective, and cognitive‑function research.

NOTICE

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.